Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
107.83 108.31 108.36 104.18 104.68 Last
9906787 9026763 8298503 13900180 9616750 Volume
+2.16% +0.45% +0.05% -3.86% +0.48% Change
Financials
Sales 2020 16 199 M 2 418 M 2 418 M
Net income 2020 2 896 M 432 M 432 M
Net cash position 2020 2 285 M 341 M 341 M
P/E ratio 2020 80,7x
Yield 2020 0,33%
Sales 2021 20 725 M 3 093 M 3 093 M
Net income 2021 3 535 M 528 M 528 M
Net cash position 2021 4 405 M 657 M 657 M
P/E ratio 2021 63,9x
Yield 2021 0,41%
Capitalization 254 B 37 935 M 37 860 M
EV / Sales 2020 15,5x
EV / Sales 2021 12,0x
Nbr of Employees 22 824
Free-Float 54,2%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing... 
Read more
More about the company
Notations Surperformance© of WuXi AppTec Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about WUXI APPTEC CO., LTD.
09/17WUXI APPTEC : Next Day Disclosure Return
PU
09/17WUXI APPTEC : Exercise of share options granted under the reserved grant of the ..
PU
09/11WUXI APPTEC : Inside information proposed disposal of a shares by a shareholder
PU
09/10SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
08/31WUXI APPTEC : Articles of association
PU
08/31WUXI APPTEC : (1) poll results of the first extraordinary general meeting of 202..
PU
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/21Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
08/19WUXI APPTEC : Completion of the repurchase and cancellation of part of the restr..
PU
08/16WUXI APPTEC : Repurchase and cancellation of part of the restricted a shares gra..
PU
08/13WUXI APPTEC : Announcement of the unaudited interim results for the six months e..
PU
08/12WUXI APPTEC : Notice of the first extraordinary general meeting for 2020
PU
08/12WUXI APPTEC : Form of proxy for the first extraordinary general meeting for 2020
PU
08/12WUXI APPTEC : Circular of the first extraordinary general meeting for 2020
PU
08/11WUXI APPTEC CO., LTD. : half-yearly earnings release
More news
News in other languages on WUXI APPTEC CO., LTD.
08/11WUXI APPTEC CO., LTD. : Veröffentlichung des Halbjahresergebnisses
08/11WUXI APPTEC CO., LTD. : publication des résultats semestriels
03/20WUXI APPTEC CO., LTD. : Veröffentlichung des Jahresergebnisses
03/20WUXI APPTEC CO., LTD. : publication des résultats annuels
2018Hong Kong parti pour être en tête du classement des IPO en 2018
More news
Analysis
China's major shareholders sell A-shares, pressuring markets
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 115,34 CNY
Last Close Price 104,18 CNY
Spread / Highest target 29,6%
Spread / Average Target 10,7%
Spread / Lowest Target -35,0%
EPS Revisions
Managers
NameTitle
Ge Li Chairman, President & Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Harry He Chairman-Supervisory Board
Guo Dong Tong Chief Operating Officer & Senior Vice President
Ellis Chu Chief Financial Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.58.33%37 775
GILEAD SCIENCES, INC.-6.45%76 214
REGENERON PHARMACEUTICALS54.42%61 014
VERTEX PHARMACEUTICALS-3.37%55 110
BEIGENE, LTD.80.38%27 097
GENMAB A/S49.17%22 988
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers Offre Binck Best of des tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2020 Surperformance. All rights reserved. Les cotations sont fournies par Factset, Morningstar,S&P Capital IQ et vwd Group